NeuroVasc Technologies, Inc. is a private company founded in 2015 and dedicated to advancing neurovascular innovation. Unlike other start-ups, NeuroVasc efforts are not just to develop a single product or single family of products, but to assemble a leading catalogue of internally developed and to address unmet needs in the treatment of neurovascular disease. Its current core product is a next-generation mechanical thrombectomy system that is designed to improve = clot retrieval capabilities in tortuous anatomy. NeuroVasc has received a CE Mark and is commercially active in Europe and Hong Kong, with 2020 commercial sales activity planned to expand into South America and Southeast Asia.